# NYX

## Overview
The NYX gene encodes the protein nyctalopin, a small leucine-rich proteoglycan that plays a pivotal role in the visual signaling pathway within the retina. Nyctalopin is primarily involved in the synaptic transmission between photoreceptors and depolarizing bipolar cells (DBCs), where it facilitates the proper localization and function of the TRPM1 channel, a critical component of the mGluR6 signal transduction cascade. This protein is anchored to the cell membrane via a glycosylphosphatidylinositol (GPI) anchor, which is essential for its extracellular orientation and interaction with other proteins. Mutations in the NYX gene are linked to X-linked complete congenital stationary night blindness (CSNB1), a condition characterized by impaired night vision and other ocular symptoms. The structural features of nyctalopin, including its leucine-rich repeats, are crucial for its role in maintaining the integrity of visual signaling pathways (Zeitz2003NYX(Nyctalopin; BechHansen2000Mutations; Pearring2011A).

## Structure
The NYX gene encodes the nyctalopin protein, which is a member of the small leucine-rich proteoglycan (SLRP) family. The primary structure of nyctalopin consists of 481 amino acids, featuring 11 leucine-rich repeats (LRRs) flanked by cysteine-rich LRRs at both the N- and C-terminal ends (Zeitz2003NYX(Nyctalopin; BechHansen2000Mutations). These LRRs are crucial for mediating protein-protein interactions, which are essential for its function in the retina (Zeitz2003NYX(Nyctalopin).

The secondary structure of nyctalopin is characterized by these LRR motifs, which form a structural framework that facilitates interactions with other proteins (Dai2015Two). The tertiary structure involves the overall 3D conformation of the protein, which is stabilized by the LRRs and their flanking cysteine-rich regions (Morgans2006Localization).

Nyctalopin is anchored to the cell membrane via a glycosylphosphatidylinositol (GPI) anchor, which is crucial for its localization and function on the cell surface (Zeitz2003NYX(Nyctalopin). The protein is predicted to be extracellularly oriented, with its LRR domain protruding into the extracellular space (Low2021Small). The GPI anchor is essential for the protein's retention at the plasma membrane, as constructs lacking this anchor show reduced surface localization (Zeitz2003NYX(Nyctalopin). 

Post-translational modifications, such as glycosylation, are suggested by the presence of putative glycosylation sites, which may influence the protein's function and localization (BechHansen2000Mutations). The quaternary structure of nyctalopin is not well-defined, as it may not form multi-subunit complexes.

## Function
Nyctalopin, encoded by the NYX gene, is a small leucine-rich proteoglycan that plays a critical role in the visual process by facilitating synaptic transmission between photoreceptors and depolarizing bipolar cells (DBCs) in the retina. It is essential for the proper localization of the TRPM1 channel to the dendrites of DBCs, which is crucial for normal visual signaling (Pearring2024Nyctalopin; Pearring2011A). Nyctalopin is anchored to the cell membrane and is thought to interact with TRPM1, potentially through its leucine-rich repeat domain, which may facilitate binding to other proteins or cell matrix components (Zeitz2003NYX(Nyctalopin; Pearring2011A).

In healthy cells, nyctalopin ensures the stability and trafficking of TRPM1, allowing it to be properly assembled and localized at the dendritic tips of DBCs. This localization is necessary for the TRPM1 channel to function in the mGluR6 signal transduction cascade, which is involved in the depolarization of bipolar cells in response to light (Pearring2024Nyctalopin; Gregg2007Nyctalopin). The absence of nyctalopin disrupts this signaling pathway, leading to conditions such as congenital stationary night blindness (CSNB) (BechHansen2000Mutations).

## Clinical Significance
Mutations in the NYX gene, which encodes the protein nyctalopin, are primarily associated with X-linked complete congenital stationary night blindness (CSNB1), a non-progressive retinal disorder characterized by impaired night vision and other ocular symptoms such as myopia, hyperopia, nystagmus, and reduced visual acuity (Zeitz2003NYX(Nyctalopin). This condition results from disrupted signal transmission between photoreceptors and bipolar cells in the retina, specifically affecting the ON-pathway (BechHansen2000Mutations; Zeitz2015Congenital).

The NYX gene has been found to harbor various mutations, including nonsense, missense, frameshift mutations, and deletions, which lead to the absence or dysfunction of nyctalopin, disrupting its role in the retina (BechHansen2000Mutations; Zeitz2015Congenital). For instance, a nonsense mutation (W350X) changes a tryptophan codon to a stop codon, potentially affecting the protein's membrane tethering (BechHansen2000Mutations). A 24-bp deletion observed in multiple families results in the loss of eight amino acids from nyctalopin, suggesting a common founder mutation among certain families (BechHansen2000Mutations).

The clinical presentation of CSNB can vary, with some patients experiencing severe visual acuity reduction and others having better visual acuity but with high refractive error and nyctalopia (Dai2015Two). The identification of NYX mutations provides evidence that NYX is the CSNB1 gene, highlighting its clinical significance in diagnosing and understanding the genetic basis of this condition (BechHansen2000Mutations).

## Interactions
Nyctalopin (NYX) is known to interact with several key proteins in the retina, playing a crucial role in visual signaling. One of its primary interactions is with the TRPM1 channel, a non-selective cation channel essential for the light response in retinal depolarizing bipolar cells (DBCs). Nyctalopin is necessary for the proper localization of TRPM1 to the dendritic tips of DBCs, and this interaction is critical for TRPM1's function in the visual signaling pathway (Pearring2011A). The interaction between nyctalopin and TRPM1 has been confirmed through various experimental approaches, including co-immunoprecipitation and membrane yeast two-hybrid assays, which demonstrate a direct binding relationship (Pearring2011A).

Nyctalopin also interacts with the metabotropic glutamate receptor mGluR6, forming a macromolecular complex that is essential for ON-bipolar cell signaling. This complex is crucial for the postsynaptic accumulation of TRPM1, which is dependent on mGluR6, highlighting nyctalopin's role as a scaffold for these signaling components (Cao2011TRPM1). These interactions underscore nyctalopin's importance in maintaining the integrity and function of the visual signaling pathway in the retina.


## References


1. (Pearring2024Nyctalopin) Nyctalopin is required for localization of the TRPM1 channel to the retinal depolarizing bipolar cell dendrites. This article has 0 citations.

[2. (Dai2015Two) Shuzhen Dai, Ming Ying, Kai Wang, Liming Wang, Ruifang Han, Peng Hao, and Ningdong Li. Two novel nyx gene mutations in the chinese families with x-linked congenital stationary night blindness. Scientific Reports, August 2015. URL: http://dx.doi.org/10.1038/srep12679, doi:10.1038/srep12679. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep12679)

[3. (BechHansen2000Mutations) N.Torben Bech-Hansen, Margaret J. Naylor, Tracy A. Maybaum, Rebecca L. Sparkes, Ben Koop, David G. Birch, Arthur A.B. Bergen, Clemens F.M. Prinsen, Robert C. Polomeno, Andreas Gal, Arlene V. Drack, Maria A. Musarella, Samuel G. Jacobson, Rockefeller S.L. Young, and Richard G. Weleber. Mutations in nyx, encoding the leucine-rich proteoglycan nyctalopin, cause x-linked complete congenital stationary night blindness. Nature Genetics, 26(3):319–323, November 2000. URL: http://dx.doi.org/10.1038/81619, doi:10.1038/81619. This article has 237 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/81619)

[4. (Zeitz2015Congenital) Christina Zeitz, Anthony G. Robson, and Isabelle Audo. Congenital stationary night blindness: an analysis and update of genotype–phenotype correlations and pathogenic mechanisms. Progress in Retinal and Eye Research, 45:58–110, March 2015. URL: http://dx.doi.org/10.1016/j.preteyeres.2014.09.001, doi:10.1016/j.preteyeres.2014.09.001. This article has 272 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.preteyeres.2014.09.001)

[5. (Low2021Small) Shermaine W. Y. Low, Thomas B. Connor, Iris S. Kassem, Deborah M. Costakos, and Shyam S. Chaurasia. Small leucine-rich proteoglycans (slrps) in the retina. International Journal of Molecular Sciences, 22(14):7293, July 2021. URL: http://dx.doi.org/10.3390/ijms22147293, doi:10.3390/ijms22147293. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms22147293)

[6. (Morgans2006Localization) Catherine W. Morgans, Gaoying Ren, and Lakshmi Akileswaran. Localization of nyctalopin in the mammalian retina. European Journal of Neuroscience, 23(5):1163–1171, March 2006. URL: http://dx.doi.org/10.1111/j.1460-9568.2006.04647.x, doi:10.1111/j.1460-9568.2006.04647.x. This article has 56 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/j.1460-9568.2006.04647.x)

[7. (Pearring2011A) J. N. Pearring, P. Bojang, Y. Shen, C. Koike, T. Furukawa, S. Nawy, and R. G. Gregg. A role for nyctalopin, a small leucine-rich repeat protein, in localizing the trp melastatin 1 channel to retinal depolarizing bipolar cell dendrites. Journal of Neuroscience, 31(27):10060–10066, July 2011. URL: http://dx.doi.org/10.1523/jneurosci.1014-11.2011, doi:10.1523/jneurosci.1014-11.2011. This article has 79 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1523/jneurosci.1014-11.2011)

[8. (Cao2011TRPM1) Yan Cao, Ekaterina Posokhova, and Kirill A. Martemyanov. Trpm1 forms complexes with nyctalopinin vivoand accumulates in postsynaptic compartment of on-bipolar neurons in mglur6-dependent manner. The Journal of Neuroscience, 31(32):11521–11526, August 2011. URL: http://dx.doi.org/10.1523/jneurosci.1682-11.2011, doi:10.1523/jneurosci.1682-11.2011. This article has 79 citations.](https://doi.org/10.1523/jneurosci.1682-11.2011)

[9. (Zeitz2003NYX(Nyctalopin) Christina Zeitz, Harry Scherthan, Susanne Freier, Silke Feil, Vanessa Suckow, Susann Schweiger, and Wolfgang Berger. Nyx(nyctalopin on chromosome x), the gene mutated in congenital stationary night blindness, encodes a cell surface protein. Investigative Opthalmology &amp; Visual Science, 44(10):4184, October 2003. URL: http://dx.doi.org/10.1167/IOVS.03-0251, doi:10.1167/iovs.03-0251. This article has 37 citations.](https://doi.org/10.1167/IOVS.03-0251)

[10. (Gregg2007Nyctalopin) Ronald G. Gregg, Maarten Kamermans, Jan Klooster, Peter D. Lukasiewicz, Neal S. Peachey, Kirstan A. Vessey, and Maureen A. McCall. Nyctalopin expression in retinal bipolar cells restores visual function in a mouse model of complete x-linked congenital stationary night blindness. Journal of Neurophysiology, 98(5):3023–3033, November 2007. URL: http://dx.doi.org/10.1152/jn.00608.2007, doi:10.1152/jn.00608.2007. This article has 75 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1152/jn.00608.2007)